-
Top Stories: Calithera Biosciences (NASDAQ:CALA), Protalix BioTherapeutics (NYSEMKT:PLX), KaloBios Pharmaceuticals (NASDAQ:KBIO), Keryx Biopharmaceuticals Inc. (NASDAQ:KERX), TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG)
On Thursday shares of Calithera Biosciences, Inc. (NASDAQ:CALA) closed at $12.14. Company’s EPS growth for next 5 years is recorded as 75.00%.Calithera Biosciences, Inc. (NASDAQ:CALA) announced its participated at the Bank of America Merrill Lynch 2015 Healthcare Conference, on Tuesday, May 12, 2015 at 8:00 a.m. Pacific Time at The Encore at Wynn Hotel in…
-
Investors Watch List: Calithera Biosciences (NASDAQ:CALA), Relypsa (NASDAQ:RLYP), DreamWorks Animation SKG Inc. (NASDAQ:DWA), Resolute Energy Corporation (NYSE:REN), Ford Motor (NYSE:F)
On Friday shares of Calithera Biosciences, Inc. (NASDAQ:CALA) closed at $13.87. Company’s EPS growth for next 5 years is recorded as 75.00%. Calithera Biosciences Inc (NADAQ:CALA) declared its financial results for the first quarter ended March 31, 2015. As of March 31, 2015, cash, cash equivalents and investments totaled $94.3 million. “During the first quarter,…
-
Top Stories: Cerus Corporation (NASDAQ:CERS), Calithera Biosciences (NASDAQ:CALA), Toyota Motor Corporation (NYSE:TM), Comcast Corporation (NASDAQ:CMCSA), IAMGOLD Corp. (NYSE:IAG)
On Tuesday shares of Cerus Corporation (NASDAQ:CERS) closed at $4.49. Cerus Corporation (NASDAQ:CERS) announced financial results for the first quarter ended March 31, 2015. Revenue for the first quarter of 2015 was $7.7 million, reflecting an increase in INTERCEPT disposable kit demand of 17% and a 2% decrease in reported revenue from the first quarter…
-
Why Making Dramatic Moves: Calithera Biosciences (NASDAQ:CALA), Bio-Techne Corp. (NASDAQ:TECH), Edgewater Technology Inc. (NASDAQ:EDGW), DreamWorks Animation (NASDAQ:DWA), Century Aluminum (NASDAQ:CENX)
On Thursday shares of Calithera Biosciences, Inc. (NASDAQ:CALA) closed at $10.01. Company’s EPS growth for next 5 years is recorded as 75.00%. Calithera Biosciences, Inc. (NASDAQ:CALA) announced that the Company’s first quarter 2015 financial results will be released on Thursday, May 7, 2015. Bio-Techne Corp. (NASDAQ:TECH) in last trading activity moved down -2.48% to close…
-
Active Stocks to Watch: KeyCorp. (NYSE:KEY), Calithera Biosciences (NASDAQ:CALA), SunTrust Banks (NYSE:STI), AbbVie Inc. (NYSE:ABBV), Windstream Holdings (NASDAQ:WIN)
On Friday shares of KeyCorp. (NYSE:KEY) closed at $14.23. Company’s sales growth for last 5 years was -7.60% and EPS growth for next 5 years is recorded as 9.69%. Announced April 16, that Cleveland-based KeyCorp. (NYSE:KEY), said its profit edged down in the first quarter but it expects improvement later this year on increasing investment-banking…
-
Top News: The PNC Financial Services Group (NYSE:PNC), Calithera Biosciences (NASDAQ:CALA), pSivida Corp. (NASDAQ:PSDV), MBIA Inc. (NYSE:MBI), Lazard (NYSE:LAZ)
On Tuesday shares of The PNC Financial Services Group, Inc. (NYSE:PNC) closed at $93.62. Company’s sales growth for last 5 years was -4.80% and EPS growth for next 5 years is recorded as 5.88%. The PNC Financial Services Group, Inc. (NYSE:PNC) reported first-quarter net income to common shares of $926 million or $1.75 per share,…
-
Stock Runners: PetroQuest Energy Inc. (NYSE:PQ), Calithera Biosciences (NASDAQ:CALA), Willbros Group Inc. (NYSE:WG), Baidu Inc (ADR) (NASDAQ:BIDU), Tremor Video (NYSE:TRMR)
On Wednesday shares of PetroQuest Energy Inc. (NYSE:PQ) closed at $2.40. Company’s sales growth for last 5 years was 0.60% and EPS growth for next 5 years is recorded as 29.00%. PetroQuest Energy, Inc. (NYSE: PQ) announced on 31 March 2015, that the Company’s bank group has completed its semi-annual re-determination of its borrowing base…
-
Morning Alert: BioLineRx, (NASDAQ:BLRX), Calithera Biosciences (NASDAQ:CALA), Alcatel Lucent SA (ADR) (NYSE:ALU), Demandware (NYSE:DWRE), Pfizer Inc. (NYSE:PFE)
On Friday shares of BioLineRx, Ltd. (NASDAQ:BLRX) closed at $2.15. Israeli biopharmaceutical company BioLineRX Ltd, Ltd. (NASDAQ:BLRX) said on Wednesday an early stage trial for a drug that uses stem cells to treat leukemia and other blood cancers met all safety and efficacy goals. Calithera Biosciences, Inc. (NASDAQ:CALA) in last trading activity advanced 9.89% to…
-
Healthcare Gainers: Calithera Biosciences (NASDAQ:CALA), ImmunoGen (NASDAQ:IMGN), NephroGenex (NASDAQ:NRX), PhotoMedex (NASDAQ:PHMD), Kamada (NASDAQ:KMDA)
On Monday shares of Calithera Biosciences, Inc. (NASDAQ:CALA) closed at $18.74. Company’s EPS growth for next 5 years is recorded as 75.00%. Calithera Biosciences, Inc. (NASDAQ:CALA), announced that the Company’s fourth quarter and year-end 2014 financial results will be released on Thursday, March 26, 2015. ImmunoGen, Inc. (NASDAQ:IMGN) in last trading activity increased 16.80% to…
-
Top News: Calithera Biosciences (NASDAQ:CALA), Actinium Pharmaceuticals (NYSEMKT:ATNM), Vodafone Group Plc (ADR) (NASDAQ:VOD), Urban Outfitters (NASDAQ:URBN), The Boeing Company (NYSE:BA)
On Thursday shares of Calithera Biosciences, Inc. (NASDAQ:CALA) closed at $14.07. Company’s EPS growth for next 5 years is recorded as 75.00%. Calithera Biosciences, Inc. (NASDAQ:CALA) announced the upcoming presentation of five preclinical abstracts, highlighting the potential of CB-839, the Company’s novel, orally bioavailable glutaminase inhibitor, at the American Association for Cancer Research, taking place…